Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:01 AM
Study NCT ID:
NCT00000442
Status:
COMPLETED
Last Update Posted:
2011-06-20
First Post:
1999-11-02
Brief Title:
Naltrexone for Relapse Prevention
Sponsor:
UConn Health
Organization:
UConn Health
Study Overview
Official Title:
Etiology and Treatment of Alcohol Dependence
Status:
COMPLETED
Status Verified Date:
2011-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is to evaluate the safety and effectiveness of an injectable slow releasing preparation of naltrexone to reduce alcohol consumption and risk of relapse in alcohol-dependent subjects Individuals will receive either naltrexone or a placebo injection for a total of three months with two subsequent followup visits spanning a 6- month period
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| P50AA003510 | NIH | None | httpsreporternihgovquickSearchP50AA003510 |